There are 2789 resources available
1213P - Clinical utility of liquid biopsy for the early diagnosis of EGFR mutant advanced lung cancer in a real-life setting (CLEAR)
Presenter: Rami Nassabein
Session: ePoster Display
1214P - High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from a phase II multicenter study, POSITION20
Presenter: Fenneke Zwierenga
Session: ePoster Display
1215P - EGFR-mutated squamous cell lung cancer and its association with outcomes
Presenter: Yang Xia
Session: ePoster Display
1216P - Effectiveness of osimertinib plus chemotherapy and avastin for EGFR-mutated advanced non-small cell lung cancer with brain metastases
Presenter: Haifeng Qin
Session: ePoster Display
1408P - Efficacy of immunotherapy in the first line treatment of advanced upper gastrointestinal tract malignancies: A pooled analysis of randomized clinical trials
Presenter: Panagiotis Ntellas
Session: ePoster Display
1409P - Cost-effectiveness of pembrolizumab plus platinum and fluoropyrimidine-based chemotherapy as first-line treatment of advanced esophageal cancer in the United States
Presenter: Tingting Qu
Session: ePoster Display
1410P - Gastric cancer: Data from the AGAMENON-SEOM study
Presenter: Ismael Macias Declara
Session: ePoster Display
1411P - A prospective, multicenter, real-world study of apatinib in the treatment of gastric cancer
Presenter: Jianping Xiong
Session: ePoster Display
Resources:
Abstract
1412P - Palliative stents in a large cohort of advanced gastroesophageal cancers (GOC): Factors associated with long term survival
Presenter: Clare Hannon
Session: ePoster Display
1413P - Antibiotic administration and outcome of patients with advanced gastric cancer receiving programmed death-1 inhibitors or with single-agent chemotherapy
Presenter: Minkyu Jung
Session: ePoster Display